Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays von Provaznikova, D., Houskova, K., Radovska, A., Salaj, P., Hrachovinova, I.

Volltext

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic von SALAJ, P., BRABEC, P., PENKA, M., POHLREICHOVA, V., SMEJKAL, P., CETKOVSKY, P., DUSEK, L., HEDNER, U.

Volltext

Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors von Salaj, P., Ovesna, P., Penka, M., Hedner, U.

Volltext

Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg−1) rFV... von Shapiro, A. D., Neufeld, E. J., Blanchette, V., Salaj, P., Gut, R. Z., Cooper, D. L.

Volltext

The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose von Křížová, P., Mášová, L., Suttnar, J., Salaj, P., Dyr, J.E., Homola, J., Pecka, M.

Volltext

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haem... von PAN-PETESCH, B., LAGUNA, P., MITAL, A., STANLEY, J., TORCHET, M. F., SALEK, S. Z., SALAJ, P.

Volltext

Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs von SANTAGOSTINO, E., MORFINI, M., AUERSWALD, G. K.-H., BENSON, G. M., ŠALEK, S. Z., LAMBERT, T., SALAJ, P., JIMENEZ-YUSTE, V., LJUNG, R. C. R.

Volltext

P291 Retrospective analysis of 51 cases with life threatening peripartal hemorrhage treated with recombinant activated factor VIIa von Binder, T., Vavřinková, B., Salaj, P.

Volltext

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management von VALENTINO, L. A., MAMONOV, V., HELLMANN, A., QUON, D. V., CHYBICKA, A., SCHROTH, P., PATRONE, L., WONG, W.‐Y.

Volltext

Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa von SALAJ, P., GURLICH, R., ŠVORCOVÁ, V., MARKOVÁ, M., CETKOVSKÝ, P.

Volltext

Early treatment benefits: analyses from HemoRec registry von SALAJ, P.

Volltext

PB0237 Inhibitor in Congenital FXI Deficiency von Fenclová, T., Provaznikova, D., Liskova, R., Radovska, A., Simonikova, M., Louzil, J., Cespivová, D., Marecek, F., Salaj, P., Hrachovinova, I.

Volltext

The role of tissue factor in thrombosis and hemostasis von Malý, M A, Tomasov, P, Hájek, P, Blasko, P, Hrachovinová, I, Salaj, P, Veselka, J

Volltext

PO-66 Abnormal fibrin formation secondary to multiple myeloma von Dyr, J.E, Kotlín, R, Riedel, T, Salaj, P, Suttnar, J, Klener, P

Volltext

P047 Acquired dysfibrinogenemia associated with multiple myeloma von Kotlín, R, Sobotková, A, Suttnar, J, Salaj, P, Riedel, T, Dyr, J.E

Volltext

Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome von Malý, M, Vojácek, J, Hrabos, V, Kvasnicka, J, Salaj, P, Durdil, V

Volltext

Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry von Salaj, Peter, Kubes, Radovan, Cetkovsky, Petr, Capova, Irena, Penka, Miroslav, Ovesná, Petra, Mesterton, Johan, Lindgren, Peter

Volltext

P001 Acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma carrying mutated CCAAT/enhancer-binding protein alpha von Fuchs, O, Provaznikova, D, Kocova, M, Kostecka, A, Neuwirtova, R, Kobylka, P, Cermak, J, Brezinova, J, Schwarz, J, Salaj, P, Benesova, K

Volltext

Thrombophilia and pulmonary endarterectomy von Lindner, J, Jansa, P, Salaj, P, Kunstýr, J, Grus, T, Maruna, P, Bláha, J, Rubes, D, Ambroz, D, Mlejnsý, F, Linhart, A

Volltext

Safety of recombinant activated factor VII ( rFVII a) in patients with congenital haemophilia with inhibitors: overall rFVII a exposure and intervals following high (>240 μg kg −1... von Shapiro, A. D., Neufeld, E. J., Blanchette, V., Salaj, P., Gut, R. Z., Cooper, D. L.

Volltext